BlackRock’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.19M Buy
842,609
+295,399
+54% +$2.17M ﹤0.01% 3612
2025
Q1
$4.22M Buy
547,210
+15,530
+3% +$120K ﹤0.01% 3664
2024
Q4
$6.43M Buy
531,680
+17,259
+3% +$209K ﹤0.01% 3577
2024
Q3
$6.45M Buy
514,421
+14,932
+3% +$187K ﹤0.01% 3555
2024
Q2
$5.96M Buy
499,489
+327,687
+191% +$3.91M ﹤0.01% 3581
2024
Q1
$3M Sell
171,802
-10,355
-6% -$181K ﹤0.01% 3804
2023
Q4
$4.68M Buy
182,157
+171,906
+1,677% +$4.42M ﹤0.01% 3643
2023
Q3
$74.2K Buy
10,251
+7
+0.1% +$51 ﹤0.01% 4850
2023
Q2
$54K Sell
10,244
-1,083
-10% -$5.71K ﹤0.01% 4964
2023
Q1
$35.2K Sell
11,327
-12,588
-53% -$39.1K ﹤0.01% 5091
2022
Q4
$94.6K Sell
23,915
-25
-0.1% -$99 ﹤0.01% 4977
2022
Q3
$90K Buy
23,940
+429
+2% +$1.61K ﹤0.01% 5115
2022
Q2
$314K Sell
23,511
-10,300
-30% -$138K ﹤0.01% 4819
2022
Q1
$168K Sell
33,811
-494
-1% -$2.46K ﹤0.01% 5060
2021
Q4
$235K Sell
34,305
-1,791
-5% -$12.3K ﹤0.01% 5001
2021
Q3
$1.11M Sell
36,096
-1,614
-4% -$49.7K ﹤0.01% 4458
2021
Q2
$1.23M Sell
37,710
-182,524
-83% -$5.93M ﹤0.01% 4379
2021
Q1
$8.33M Buy
220,234
+40,581
+23% +$1.53M ﹤0.01% 3623
2020
Q4
$8.5M Buy
179,653
+9,454
+6% +$447K ﹤0.01% 3386
2020
Q3
$5.49M Buy
170,199
+25,403
+18% +$819K ﹤0.01% 3444
2020
Q2
$6.38M Buy
144,796
+107,363
+287% +$4.73M ﹤0.01% 3358
2020
Q1
$1.23M Buy
37,433
+1,275
+4% +$41.8K ﹤0.01% 3739
2019
Q4
$1.85M Sell
36,158
-44
-0.1% -$2.25K ﹤0.01% 3759
2019
Q3
$1.33M Sell
36,202
-609
-2% -$22.4K ﹤0.01% 3828
2019
Q2
$2.03M Sell
36,811
-72,934
-66% -$4.03M ﹤0.01% 3726
2019
Q1
$6.68M Sell
109,745
-3,126
-3% -$190K ﹤0.01% 3276
2018
Q4
$6.68M Buy
112,871
+5,212
+5% +$308K ﹤0.01% 3268
2018
Q3
$8.7M Buy
107,659
+4,058
+4% +$328K ﹤0.01% 3261
2018
Q2
$9.07M Buy
103,601
+78,781
+317% +$6.9M ﹤0.01% 3251
2018
Q1
$4.8M Buy
24,820
+1,692
+7% +$327K ﹤0.01% 3399
2017
Q4
$2.37M Hold
23,128
﹤0.01% 3599
2017
Q3
$877K Hold
23,128
﹤0.01% 3877
2017
Q2
$806K Buy
23,128
+21,867
+1,734% +$762K ﹤0.01% 3848
2017
Q1
$89K Buy
+1,261
New +$89K ﹤0.01% 4297